1090篇出版物与五年之后：针对家族性腺瘤性息肉病的诊疗一体化真的会实现吗？ - Suppr

Suppr

超能文献

1,090 Publications and 5 Years Later: Is FAP-Targeted Theranostics Really Happening?

作者信息

Haberkorn Uwe, Altmann Annette, Giesel Frederik L, Kratochwil Clemens

机构信息

Department of Nuclear Medicine, University Hospital Heidelberg, Heidelberg, Germany;

Clinical Cooperation Unit Nuclear Medicine, German Cancer Research Center, Heidelberg, Germany.

出版信息

J Nucl Med. 2024 Oct 1;65(10):1518-1520. doi: 10.2967/jnumed.124.267923.

DOI:10.2967/jnumed.124.267923

PMID:39168520

Abstract

摘要

相似文献

1,090 Publications and 5 Years Later: Is FAP-Targeted Theranostics Really Happening?

J Nucl Med. 2024 Oct 1;65(10):1518-1520. doi: 10.2967/jnumed.124.267923.

Radiomolecular Theranostics With Fibroblast-Activation-Protein Inhibitors and Peptides.

Semin Nucl Med. 2024 Jul;54(4):537-556. doi: 10.1053/j.semnuclmed.2024.05.010. Epub 2024 Jul 16.

Synthesis and Preliminary Evaluation of I-Labeled FAPI Tracers for Cancer Theranostics.

Mol Pharm. 2021 Nov 1;18(11):4179-4187. doi: 10.1021/acs.molpharmaceut.1c00566. Epub 2021 Sep 30.

Fibroblast Activation Protein Inhibitor Theranostics: Preclinical Considerations.

PET Clin. 2023 Jul;18(3):397-408. doi: 10.1016/j.cpet.2023.02.005. Epub 2023 Mar 28.

Tailoring Fibroblast-Activation Protein Targeting for Theranostics: A Comparative Preclinical Evaluation of the Ga- and Lu-Labeled Monomeric and Dimeric Fibroblast-Activation Protein Inhibitors DOTA.SA.FAPi and DOTAGA.(SA.FAPi).

Molecules. 2024 Jun 28;29(13):3093. doi: 10.3390/molecules29133093.

Theranostics Targeting Fibroblast Activation Protein in the Tumor Stroma: Cu- and Ac-Labeled FAPI-04 in Pancreatic Cancer Xenograft Mouse Models.

J Nucl Med. 2020 Apr;61(4):563-569. doi: 10.2967/jnumed.119.233122. Epub 2019 Oct 4.

Polymer Vesicles: Modular Platforms for Cancer Theranostics.

Adv Mater. 2018 Apr;30(17):e1705674. doi: 10.1002/adma.201705674. Epub 2018 Feb 16.

Theranostics based on AIEgens.

Theranostics. 2018 Sep 9;8(18):4925-4956. doi: 10.7150/thno.27787. eCollection 2018.

The Combination of Solid-State Chemistry and Medicinal Chemistry as the Basis for the Synthesis of Theranostics Platforms.

Biomolecules. 2021 Oct 19;11(10):1544. doi: 10.3390/biom11101544.

Dendritic cell-targeted theranostic nanomedicine: advanced cancer nanotechnology for diagnosis and therapy.

Nanomedicine (Lond). 2020 Apr;15(10):947-949. doi: 10.2217/nnm-2020-0032. Epub 2020 Mar 27.

引用本文的文献

The characterization of variable new antigen receptors targeting FAP isolated from a novel immunized library.

Commun Biol. 2025 Aug 13;8(1):1210. doi: 10.1038/s42003-025-08610-x.

Patent spotlight on theranostics targeting fibroblast activation protein for personalized cancer care.

Pharm Pat Anal. 2024;13(4-6):149-160. doi: 10.1080/20468954.2025.2500811. Epub 2025 May 6.

Development of FAP-targeted theranostics discovered by next-generation sequencing-augmented mining of a novel immunized VNAR library.

bioRxiv. 2025 Jan 13:2025.01.13.632555. doi: 10.1101/2025.01.13.632555.

Non-[F]FDG PET-Radiopharmaceuticals in Oncology.

Pharmaceuticals (Basel). 2024 Dec 6;17(12):1641. doi: 10.3390/ph17121641.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

1,090 Publications and 5 Years Later: Is FAP-Targeted Theranostics Really Happening?

作者信息

Haberkorn Uwe, Altmann Annette, Giesel Frederik L, Kratochwil Clemens

机构信息

Department of Nuclear Medicine, University Hospital Heidelberg, Heidelberg, Germany;

Clinical Cooperation Unit Nuclear Medicine, German Cancer Research Center, Heidelberg, Germany.

出版信息

J Nucl Med. 2024 Oct 1;65(10):1518-1520. doi: 10.2967/jnumed.124.267923.

DOI:10.2967/jnumed.124.267923

PMID:39168520

Abstract

摘要

相似文献

1,090 Publications and 5 Years Later: Is FAP-Targeted Theranostics Really Happening?

J Nucl Med. 2024 Oct 1;65(10):1518-1520. doi: 10.2967/jnumed.124.267923.

Radiomolecular Theranostics With Fibroblast-Activation-Protein Inhibitors and Peptides.

Semin Nucl Med. 2024 Jul;54(4):537-556. doi: 10.1053/j.semnuclmed.2024.05.010. Epub 2024 Jul 16.

Synthesis and Preliminary Evaluation of I-Labeled FAPI Tracers for Cancer Theranostics.

Mol Pharm. 2021 Nov 1;18(11):4179-4187. doi: 10.1021/acs.molpharmaceut.1c00566. Epub 2021 Sep 30.

Fibroblast Activation Protein Inhibitor Theranostics: Preclinical Considerations.

PET Clin. 2023 Jul;18(3):397-408. doi: 10.1016/j.cpet.2023.02.005. Epub 2023 Mar 28.

Molecules. 2024 Jun 28;29(13):3093. doi: 10.3390/molecules29133093.

Theranostics Targeting Fibroblast Activation Protein in the Tumor Stroma: Cu- and Ac-Labeled FAPI-04 in Pancreatic Cancer Xenograft Mouse Models.

J Nucl Med. 2020 Apr;61(4):563-569. doi: 10.2967/jnumed.119.233122. Epub 2019 Oct 4.

Polymer Vesicles: Modular Platforms for Cancer Theranostics.

Adv Mater. 2018 Apr;30(17):e1705674. doi: 10.1002/adma.201705674. Epub 2018 Feb 16.

Theranostics based on AIEgens.

Theranostics. 2018 Sep 9;8(18):4925-4956. doi: 10.7150/thno.27787. eCollection 2018.

The Combination of Solid-State Chemistry and Medicinal Chemistry as the Basis for the Synthesis of Theranostics Platforms.

Biomolecules. 2021 Oct 19;11(10):1544. doi: 10.3390/biom11101544.

Dendritic cell-targeted theranostic nanomedicine: advanced cancer nanotechnology for diagnosis and therapy.

Nanomedicine (Lond). 2020 Apr;15(10):947-949. doi: 10.2217/nnm-2020-0032. Epub 2020 Mar 27.

引用本文的文献

The characterization of variable new antigen receptors targeting FAP isolated from a novel immunized library.

Commun Biol. 2025 Aug 13;8(1):1210. doi: 10.1038/s42003-025-08610-x.

Patent spotlight on theranostics targeting fibroblast activation protein for personalized cancer care.

Pharm Pat Anal. 2024;13(4-6):149-160. doi: 10.1080/20468954.2025.2500811. Epub 2025 May 6.

Development of FAP-targeted theranostics discovered by next-generation sequencing-augmented mining of a novel immunized VNAR library.

bioRxiv. 2025 Jan 13:2025.01.13.632555. doi: 10.1101/2025.01.13.632555.

Non-[F]FDG PET-Radiopharmaceuticals in Oncology.

Pharmaceuticals (Basel). 2024 Dec 6;17(12):1641. doi: 10.3390/ph17121641.